文献速递肾小球疾病

蛋白尿轨迹预测IgA肾病与IgA血管炎肾炎的疾病进展

Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-04-10

在Cure Glomerulonephropathy多中心观察队列中,对368例成人和234例儿童IgA肾病/IgA血管炎肾炎患者分析发现,基于2年蛋白尿的潜在类别轨迹分组可识别进展风险。成人中最高蛋白尿轨迹组(3组)相比中间组(2组)进展至复合终点的风险显著增高,儿童中轨迹组也与eGFR下降时间相关。

要点

  • 2年蛋白尿轨迹可区分IgA肾病患者的肾脏预后风险。
  • 成人最高蛋白尿轨迹组进展风险约为中间组的2-3倍。
  • 儿童不同轨迹组的eGFR<15时间差异显著。

核心结论

  • 蛋白尿轨迹是IgA肾病患者疾病进展的主要预测因素。

研究设计与样本

  • 多中心观察性队列研究(Cure Glomerulonephropathy Network),纳入368例成人和234例儿童IgA肾病/IgA血管炎肾炎患者,分别分析全队列、新发、现患和组织学四个亚组,采用潜在类别轨迹模型基于2年蛋白尿分组,线性混合模型计算eGFR斜率,成人采用Cox模型分析复合终点。

主要发现

  • 全成人队列中,组1蛋白尿最低(IQR 0.1–0.4 g/g),组2和组3分别为中等(IQR 0.5–1.5 g/g)和较高(IQR 1.8–4.1 g/g)。
  • 全成人队列中,蛋白尿轨迹组1、2、3的平均预测eGFR<15 ml/min/1.73 m2时间分别为>90年、16年和8年;儿童队列分别为>90年、67年和11年。
  • 成人中,调整年龄、入组eGFR、免疫抑制暴露和高血压后,组3相比组2在全队列、现患队列和组织学队列中进展至复合终点的风险比分别为3.13(95%CI 1.84–5.33)、1.98(95%CI 0.97–4.06)和3.36(95%CI 1.59–7.13),但在新发队列中无显著关联。

临床怎么用

  • 临床可依据2年蛋白尿轨迹对IgA肾病患者进行风险分层,辅助患者咨询和临床试验入组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Defining risk of kidney function loss in IgA nephropathy and IgA vasculitis with nephritis is important for patient counseling and risk-based enrollment of clinical trials. Proteinuria trajectory over 2 years can uniquely identify patients at risk of loss of kidney function or kidney failure. Children and adults with the highest levels of proteinuria had a higher risk of progressive kidney disease compared with those with intermediate levels. BACKGROUND: Identifying patients with IgA nephropathy at risk of disease progression is critical for clinical decision making, risk-based patient counseling, and optimal enrollment of clinical trials. METHODS: Patients with IgA nephropathy and IgA vasculitis with nephritis were enrolled in the Cure Glomerulonephropathy Network, a multicenter observational cohort study. Children and adults were analyzed separately in four cohorts: (1) full, (2) incident, (3) prevalent, and (4) histology. Groups were defined using latent class trajectory modeling using proteinuria measurements over 2 years. Linear mixed models were used to calculate predicted eGFR slope. In adults, Cox proportional hazard models were used to model time to kidney failure or 40% eGFR decline as a function of the proteinuria trajectory group. RESULTS: Of 919 patients with IgA nephropathy/IgA vasculitis with nephritis enrolled into the Cure Glomerulonephropathy Network, 368 adults and 234 children were included in the analysis. In the full adult cohort, group 1 had the lowest levels of proteinuria (interquartile range [IQR], 0.1–0.4 g/g), while groups 2 and 3 had intermediate and higher levels of proteinuria (IQR, 0.5–1.5 and IQR, 1.8–4.1 g/g), respectively. The average predicted time to eGFR <15 ml/min per 1.73 m2 was >90, 16, and 8 years and >90, 67, and 11 years for proteinuria trajectory groups 1, 2, and 3 in the full adult and pediatric cohorts, respectively. In adults, adjusting for age, eGFR at enrollment, immunosuppression exposure, and hypertension, group 3 membership was associated with 3.13 (95% confidence interval [CI], 1.84 to 5.33), 1.98 (95% CI, 0.97 to 4.06), and 3.36 (95% CI, 1.59 to 7.13) times higher hazard of progressing to a composite outcome compared with group 2 membership in the full, prevalent, and histology cohorts, respectively, but not associated with progression in the incident cohort. CONCLUSIONS: Proteinuria trajectory is a major predictor of disease progression in patients with IgA nephropathy.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Glenn DA, Carver AW, Helmuth ME, et al. Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis. Clin J Am Soc Nephrol. 2025. PMID: 40208688. doi:10.2215/CJN.0000000707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。